Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Rapid Formation of Cerebral Microbleeds in Reversible Cerebral Vasoconstriction Syndrome.

Shoamanesh A, Hawkes C, Charidimou A, Sharma M, Ng KH.

Can J Neurol Sci. 2019 Sep 20:1-3. doi: 10.1017/cjn.2019.300. [Epub ahead of print] No abstract available.

PMID:
31625486
2.

White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy.

Boulouis G, Bricout N, Benhassen W, Ferrigno M, Turc G, Bretzner M, Benzakoun J, Seners P, Personnic T, Legrand L, Trystram D, Rodriguez-Regent C, Charidimou A, Rost NS, Bracard S, Cordonnier C, Oppenheim C, Naggara O, Henon H.

Neurology. 2019 Oct 15;93(16):e1498-e1506. doi: 10.1212/WNL.0000000000008317. Epub 2019 Sep 13.

PMID:
31519778
3.

Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.

Charidimou A, Frosch MP, Salman RA, Baron JC, Cordonnier C, Hernandez-Guillamon M, Linn J, Raposo N, Rodrigues M, Romero JR, Schneider JA, Schreiber S, Smith EE, van Buchem MA, Viswanathan A, Wollenweber FA, Werring DJ, Greenberg SM; International CAA Association.

Int J Stroke. 2019 Sep 12:1747493019855888. doi: 10.1177/1747493019855888. [Epub ahead of print]

PMID:
31514686
4.

Comorbid Atrial Fibrillation in Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage: Between a Rock and a Hard Place.

Shoamanesh A, Charidimou A, Sheth KN.

J Stroke Cerebrovasc Dis. 2019 Sep 5:104351. doi: 10.1016/j.jstrokecerebrovasdis.2019.104351. [Epub ahead of print] No abstract available.

PMID:
31495667
5.

Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy.

Xiong L, Charidimou A, Pasi M, Boulouis G, Pongpitakmetha T, Schirmer MD, Singh S, Benson E, Gurol EM, Rosand J, Greenberg SM, Biffi A, Viswanathan A.

J Alzheimers Dis. 2019;71(2):435-442. doi: 10.3233/JAD-190346.

PMID:
31403947
6.

Standards for Detecting, Interpreting, and Reporting Noncontrast Computed Tomographic Markers of Intracerebral Hemorrhage Expansion.

Morotti A, Boulouis G, Dowlatshahi D, Li Q, Barras CD, Delcourt C, Yu Z, Zheng J, Zhou Z, Aviv RI, Shoamanesh A, Sporns PB, Rosand J, Greenberg SM, Al-Shahi Salman R, Qureshi AI, Demchuk AM, Anderson CS, Goldstein JN, Charidimou A; International NCCT ICH Study Group.

Ann Neurol. 2019 Oct;86(4):480-492. doi: 10.1002/ana.25563. Epub 2019 Aug 24. Review.

PMID:
31364773
7.

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.

Wilson D, Ambler G, Shakeshaft C, Banerjee G, Charidimou A, Seiffge D, White M, Cohen H, Yousry T, Salman R, Lip GYH, Muir K, Brown MM, Jäger HR, Werring DJ; CROMIS-2 collaborators.

BMJ Open. 2019 Jul 24;9(7):e028387. doi: 10.1136/bmjopen-2018-028387.

8.

APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.

Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A.

Neurology. 2019 Jul 23;93(4):e358-e371. doi: 10.1212/WNL.0000000000007818. Epub 2019 Jun 26.

PMID:
31243071
9.

Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy.

Pasi M, Pongpitakmetha T, Charidimou A, Singh SD, Tsai HH, Xiong L, Boulouis G, Warren AD, Rosand J, Frosch MP, Viswanathan A, Gurol ME, Greenberg SM.

Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4. Erratum in: Stroke. 2019 Aug;50(8):e240.

PMID:
31159702
10.

Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies.

Das AS, Regenhardt RW, Vernooij MW, Blacker D, Charidimou A, Viswanathan A.

J Stroke. 2019 May;21(2):121-138. doi: 10.5853/jos.2018.03608. Epub 2019 Apr 17. Review.

11.

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.

Jang H, Jang YK, Kim HJ, Werring DJ, Lee JS, Choe YS, Park S, Lee J, Kim KW, Kim Y, Cho SH, Kim SE, Kim SJ, Charidimou A, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1287-1298. doi: 10.1007/s00259-019-04314-7. Epub 2019 Apr 2.

PMID:
30937462
12.

Cortical Superficial Siderosis Evolution.

Charidimou A, Boulouis G, Xiong L, Pasi M, Roongpiboonsopit D, Ayres A, Schwab KM, Rosand J, Gurol ME, Viswanathan A, Greenberg SM.

Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.

PMID:
30869563
13.

Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis.

Charidimou A, Boulouis G, Roongpiboonsopit D, Xiong L, Pasi M, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A.

Int J Stroke. 2019 Feb 20:1747493019830065. doi: 10.1177/1747493019830065. [Epub ahead of print]

PMID:
30785378
14.

Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysis.

Yakushiji Y, Wilson D, Ambler G, Charidimou A, Beiser A, van Buchem MA, DeCarli C, Ding D, Gudnason V, Hara H, Imaizumi T, Kohara K, Kwon HM, Launer LJ, Mok V, Phan T, Preis SR, Romero JR, Seshadri S, Srikanth V, Takashima Y, Tsushima Y, Wang Z, Wolf PA, Xiong Y, Yamaguchi S, Werring DJ.

Neurology. 2019 Mar 5;92(10):e1086-e1097. doi: 10.1212/WNL.0000000000007039. Epub 2019 Feb 1. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30709966
15.

Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy.

van Veluw SJ, Reijmer YD, van der Kouwe AJ, Charidimou A, Riley GA, Leemans A, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM.

Neurology. 2019 Feb 26;92(9):e933-e943. doi: 10.1212/WNL.0000000000007005. Epub 2019 Jan 30.

PMID:
30700595
16.

Microbleeds evolution and remote hemorrhage post-tPA: "Red meets white" revisited.

Charidimou A, Pasi M.

Neurology. 2019 Feb 12;92(7):307-308. doi: 10.1212/WNL.0000000000006933. Epub 2019 Jan 23. No abstract available.

PMID:
30674598
17.

Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage.

Pasi M, Charidimou A, Boulouis G, Fotiadis P, Morotti A, Xiong L, Marini S, Ayres A, Frosch MP, Goldstein JN, Rosand J, Gurol ME, Greenberg SM, Viswanathan A.

J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.

PMID:
30617995
18.

Ambient Pollutants and Spontaneous Intracerebral Hemorrhage in Greater Boston.

Wilker EH, Mostofsky E, Fossa A, Koutrakis P, Warren A, Charidimou A, Mittleman MA, Viswanathan A.

Stroke. 2018 Oct 18:2764-2766. doi: 10.1161/STROKEAHA.118.023128. [Epub ahead of print]

PMID:
30580707
19.

Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy.

Xiong L, van Veluw SJ, Bounemia N, Charidimou A, Pasi M, Boulouis G, Reijmer YD, Giese AK, Davidsdottir S, Fotiadis P, Valenti R, Riley G, Schwab K, Gurol EM, Biffi A, Greenberg SM, Viswanathan A.

Stroke. 2018 Oct;49(10):2330-2336. doi: 10.1161/STROKEAHA.118.022280.

20.

Integration of Computed Tomographic Angiography Spot Sign and Noncontrast Computed Tomographic Hypodensities to Predict Hematoma Expansion.

Morotti A, Boulouis G, Charidimou A, Schwab K, Kourkoulis C, Anderson CD, Gurol ME, Viswanathan A, Romero JM, Greenberg SM, Rosand J, Goldstein JN.

Stroke. 2018 Sep;49(9):2067-2073. doi: 10.1161/STROKEAHA.118.022010.

21.

Author response: Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.

Charidimou A.

Neurology. 2018 Sep 25;91(13):635. doi: 10.1212/WNL.0000000000006237. No abstract available.

PMID:
30249674
22.

Journal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.

Charidimou A, Giese AK, Pasi M, van Veluw SJ, Xiong L, Fotiadis P, Marini S, Schirmer MD, Viswanathan A.

Neurology. 2018 Sep 18;91(12):574-577. doi: 10.1212/WNL.0000000000006195. No abstract available. Erratum in: Neurology. 2019 Jul 9;93(2):e88.

23.

Domain-specific characterisation of early cognitive impairment following spontaneous intracerebral haemorrhage.

Banerjee G, Summers M, Chan E, Wilson D, Charidimou A, Cipolotti L, Werring DJ.

J Neurol Sci. 2018 Aug 15;391:25-30. doi: 10.1016/j.jns.2018.05.015. Epub 2018 May 21.

PMID:
30103965
24.

Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy.

Martinez-Ramirez S, van Rooden S, Charidimou A, van Opstal AM, Wermer M, Gurol ME, Terwindt G, van der Grond J, Greenberg SM, van Buchem M, Viswanathan A.

Stroke. 2018 Aug;49(8):1913-1919. doi: 10.1161/STROKEAHA.118.021137.

25.

How to Organize a Journal Club for Fellows and Residents.

Xiong L, Giese AK, Pasi M, Charidimou A, van Veluw S, Viswanathan A.

Stroke. 2018 Sep;49(9):e283-e285. doi: 10.1161/STROKEAHA.118.021728. No abstract available.

PMID:
30002150
26.

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.

Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, Lip GYH, Cohen H, Banerjee G, Houlden H, White MJ, Yousry TA, Harkness K, Flossmann E, Smyth N, Shaw LJ, Warburton E, Muir KW, Jäger HR, Werring DJ; CROMIS-2 collaborators.

Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16. Erratum in: Lancet Neurol. 2018 Jul;17(7):578.

27.

Consensus Needed for Noncontrast CT Markers in Intracerebral Hemorrhage.

Boulouis G, Charidimou A, Morotti A.

AJNR Am J Neuroradiol. 2018 Jun;39(6):E78-E79. doi: 10.3174/ajnr.A5604. Epub 2018 Apr 26. No abstract available.

28.

Author Correction: Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

Jang YK, Kim HJ, Lee JS, Kim YJ, Kim KW, Kim Y, Jang H, Lee J, Lee JM, Kim SJ, Yu KH, Charidimou A, Werring DJ, Kim ST, Na DL, Seo SW.

Sci Rep. 2018 Mar 21;8(1):5196. doi: 10.1038/s41598-018-23383-6.

29.

Reversible sub-acute cognitive deterioration in cerebral amyloid angiopathy: A case report.

Pasi M, Xiong L, Charidimou A, Viswanathan A.

J Neurol Sci. 2018 Feb 15;385:215-216. doi: 10.1016/j.jns.2018.01.001. Epub 2018 Jan 3. No abstract available.

PMID:
29406906
30.

Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.

Charidimou A, Friedrich JO, Greenberg SM, Viswanathan A.

Neurology. 2018 Feb 27;90(9):e754-e762. doi: 10.1212/WNL.0000000000005030. Epub 2018 Jan 31. Review.

31.

Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1).

Charidimou A, Shams S, Romero JR, Ding J, Veltkamp R, Horstmann S, Eiriksdottir G, van Buchem MA, Gudnason V, Himali JJ, Gurol ME, Viswanathan A, Imaizumi T, Vernooij MW, Seshadri S, Greenberg SM, Benavente OR, Launer LJ, Shoamanesh A; International META-MICROBLEEDS Initiative.

Int J Stroke. 2018 Jul;13(5):454-468. doi: 10.1177/1747493017751931. Epub 2018 Jan 17.

32.

Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.

Greenberg SM, Charidimou A.

Stroke. 2018 Feb;49(2):491-497. doi: 10.1161/STROKEAHA.117.016990. Epub 2018 Jan 15. Review. No abstract available.

33.

Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk.

Pasi M, Charidimou A, Boulouis G, Auriel E, Ayres A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Pantoni L, Greenberg SM, Gurol ME.

Neurology. 2018 Jan 9;90(2):e119-e126. doi: 10.1212/WNL.0000000000004797. Epub 2017 Dec 15.

34.

Cerebellar Hematoma Location: Implications for the Underlying Microangiopathy.

Pasi M, Marini S, Morotti A, Boulouis G, Xiong L, Charidimou A, Ayres AM, Lee MJ, Biffi A, Goldstein JN, Rosand J, Gurol ME, Greenberg SM, Viswanathan A.

Stroke. 2018 Jan;49(1):207-210. doi: 10.1161/STROKEAHA.117.019286. Epub 2017 Nov 28.

35.

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

Jang YK, Kim HJ, Lee JS, Kim YJ, Kim KW, Kim Y, Jang H, Lee J, Lee JM, Kim SJ, Yu KH, Charidimou A, Werring DJ, Kim ST, Na DL, Seo SW.

Sci Rep. 2017 Nov 22;7(1):15984. doi: 10.1038/s41598-017-16298-1. Erratum in: Sci Rep. 2018 Mar 21;8(1):5196.

36.

Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach.

Charidimou A, Shoamanesh A, Al-Shahi Salman R, Cordonnier C, Perry LA, Sheth KN, Biffi A, Rosand J, Viswanathan A.

Int J Stroke. 2018 Feb;13(2):117-120. doi: 10.1177/1747493017741384. Epub 2017 Nov 9.

37.

Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF.

Charidimou A, Karayiannis C, Song TJ, Orken DN, Thijs V, Lemmens R, Kim J, Goh SM, Phan TG, Soufan C, Chandra RV, Slater LA, Haji S, Mok V, Horstmann S, Leung KT, Kawamura Y, Sato N, Hasebe N, Saito T, Wong LKS, Soo Y, Veltkamp R, Flemming KD, Imaizumi T, Srikanth V, Heo JH; International META-MICROBLEEDS Initiative.

Neurology. 2017 Dec 5;89(23):2317-2326. doi: 10.1212/WNL.0000000000004704. Epub 2017 Nov 8. Review.

PMID:
29117953
38.

Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?

Shoamanesh A, Charidimou A, Sharma M, Hart RG.

Stroke. 2017 Dec;48(12):3408-3412. doi: 10.1161/STROKEAHA.117.018467. Epub 2017 Nov 7. No abstract available.

PMID:
29114097
39.

Total small vessel disease burden and brain network efficiency in cerebral amyloid angiopathy.

Valenti R, Reijmer YD, Charidimou A, Boulouis G, Martinez SR, Xiong L, Fotiadis P, Jessel M, Ayres A, Riley G, Pantoni L, Edip Gurol M, Greenberg SM, Viswanathan A.

J Neurol Sci. 2017 Nov 15;382:10-12. doi: 10.1016/j.jns.2017.09.015. Epub 2017 Sep 12.

40.

Defining retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Charidimou A.

Brain. 2016 Nov 1;139(11):2819-2821. doi: 10.1093/brain/aww253. No abstract available.

PMID:
29106489
41.

Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: A prospective study.

Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, van Etten ES, Martinez-Ramirez S, Ayres A, Vashkevich A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Greenberg SM, Gurol ME.

Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.

42.

Evolution of DWI lesions in cerebral amyloid angiopathy: Evidence for ischemia.

van Veluw SJ, Lauer A, Charidimou A, Bounemia N, Xiong L, Boulouis G, Fotiadis P, Ayres A, Gurol ME, Viswanathan A, Greenberg SM, Vernooij MW.

Neurology. 2017 Nov 21;89(21):2136-2142. doi: 10.1212/WNL.0000000000004668. Epub 2017 Oct 25.

43.

Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.

Charidimou A, Farid K, Tsai HH, Tsai LK, Yen RF, Baron JC.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):410-417. doi: 10.1136/jnnp-2017-316851. Epub 2017 Oct 25.

PMID:
29070646
44.

Acute convexity subarachnoid haemorrhage and cortical superficial siderosis in probable cerebral amyloid angiopathy without lobar haemorrhage.

Charidimou A, Boulouis G, Fotiadis P, Xiong L, Ayres AM, Schwab KM, Gurol ME, Rosand J, Greenberg SM, Viswanathan A.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):397-403. doi: 10.1136/jnnp-2017-316368. Epub 2017 Oct 20.

PMID:
29054916
45.

Total Small Vessel Disease Score in Neurologically Healthy Japanese Adults in the Kashima Scan Study.

Yakushiji Y, Charidimou A, Noguchi T, Nishihara M, Eriguchi M, Nanri Y, Kawaguchi A, Hirotsu T, Werring DJ, Hara H.

Intern Med. 2018 Jan 15;57(2):189-196. doi: 10.2169/internalmedicine.8393-16. Epub 2017 Oct 16.

46.

Response by Werring and Charidimou to Letter Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis".

Werring DJ, Charidimou A; authors.

Stroke. 2017 Nov;48(11):e332. doi: 10.1161/STROKEAHA.117.019038. Epub 2017 Oct 13. No abstract available.

PMID:
29030477
47.

Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.

Boulouis G, Morotti A, Pasi M, Goldstein JN, Gurol ME, Charidimou A.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):263-270. doi: 10.1136/jnnp-2017-316631. Epub 2017 Oct 13.

PMID:
29030422
48.

Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy.

Boulouis G, Lauer A, Siddiqui AK, Charidimou A, Regenhardt RW, Viswanathan A, Rost N, Leslie-Mazwi TM, Schwamm LH.

JAMA Neurol. 2017 Nov 1;74(11):1361-1367. doi: 10.1001/jamaneurol.2017.2149.

49.

Meta-analysis methodology in the microbleeds field: The relevance of the clinical question and study quality in choosing the most appropriate model.

Charidimou A, Boulouis G, Shams S, Calvet D, Shoamanesh A; International META-MICROBLEEDS Initiative.

J Neurol Sci. 2017 Oct 15;381:348-349. doi: 10.1016/j.jns.2017.09.025. Epub 2017 Sep 19. No abstract available.

PMID:
28947333
50.

Multiple neuropathologies and dementia in the aging brain: a key role for cerebrovascular disease?

Charidimou A, Viswanathan A.

Alzheimers Dement (N Y). 2016 Nov;2(4):281-282. doi: 10.1016/j.trci.2016.11.001. Epub 2016 Nov 29. No abstract available.

Supplemental Content

Loading ...
Support Center